Liang Li

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Multiple Myeloma

Acute Lymphoblastic Leukemia

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

European journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Andrea C Baines, Rachel Ershler, Bindu Kanapuru, Qing Xu, Guoxiang Shen, Liang Li, Lian Ma, Olanrewaju O Okusanya, Natalie E Simpson, Wanda Nguyen, Marc R Theoret, Richard Pazdur, Nicole J Gormley
FDA Approval Summary: Belantamab Mafodotin for Patients with Relapsed or Refractory Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Wenjun Chen, Liang Li, Shuangmin Ji, Xuyang Song, Wei Lu, Tianyan Zhou
Longitudinal model-based meta-analysis for survival probabilities in patients with castration-resistant prostate cancer. European journal of clinical pharmacology 76 (4) (2020)
Emily Y Jen, Xin Gao, Liang Li, Luning Zhuang, Natalie E Simpson, Baikuntha Aryal, Rong Wang, Donna Przepiorka, Yuan Li Shen, Ruby Leong, Chao Liu, Christopher M Sheth, Steven Bowen, Kirsten B Goldberg, Ann T Farrell, Gideon M Blumenthal, Richard Pazdur
FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (3) (2019)